SCHEMBL5111657

SCHEMBL5111657

COc1ccc(C(c2ccccc2F)S(=O)(=O)C(c2ccc(OC)cc2)c2ccccc2F)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.49
MEN1 O00255 2/20 0.49
PKM P14618 4/20 0.44
ALDH1A1 P00352 3/20 0.44
MAPT P10636 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
KDM4E B2RXH2 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
ACP3 P15309 1/20 0.41
PKLR P30613 1/20 0.40
RELA Q04206 2/20 0.40
NFE2L2 Q16236 2/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
ACHE P22303 1/20 0.40
GAA P10253 2/20 0.39
TP53 P04637 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3886900 0.81 IDO1 (0.46) KMT2AMEN1ALDH1A1MAPTGAA
SCHEMBL13517305 0.71 HTT (0.49) KMT2AMEN1PKMALDH1A1MAPT
SCHEMBL13271825 0.68 MEN1 (0.62) KMT2AMEN1PKMALDH1A1MAPT
SCHEMBL1784072 0.68 MEN1 (0.62) KMT2AMEN1PKMALDH1A1MAPT
SCHEMBL29446276 0.67 KMT2A (0.42) KMT2AMEN1PKMALDH1A1MAPT
SCHEMBL3884132 0.66 CYP3A4 (0.40) KMT2AMEN1ALDH1A1MAPTL3MBTL1
SCHEMBL1937195 0.65 KMT2A (0.45) KMT2AMEN1PKMALDH1A1MAPT
SCHEMBL22049906 0.64 SMN1; SMN2 (0.51) KMT2AMEN1PKMALDH1A1MAPT
Anisole SCHEMBL4618570 0.63 CA4 (0.70) PKMALDH1A1NFE2L2CA1CA2
SCHEMBL25316723 0.63 CA1 (0.55) KMT2AMEN1PKMALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7342027-B2 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2008-03-11 US disclosed
US-20050234057-A1 1-Phenylpiperidin-3-one derivatives and processes for the preparation thereof DONG-A PHARMACEUTICAL CO., LTD. (KR) 2005-10-20 US disclosed
WO-2004011457-A1 1-PHENYLPIPERIDIN-3-ONE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2004-02-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234057-A1 1-Phenylpiperidin-3-one derivatives and processes for the preparation thereof CTRL, PRCP, CLPP KMT2A 4201/4885MEN1 3518/4885PKM 1708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.